<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two children with severe and moderate <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> received combination treatment with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, antilymphocyte globulin and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>One child (severe type) was given 2 courses of high dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> during the last 4 weeks without improvement prior to this combination therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The other child (moderate type) was not previously treated </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients showed complete response within 3 months following this therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Serious side effects were not observed </plain></SENT>
<SENT sid="5" pm="."><plain>Combination therapy of these three drugs may be beneficial for patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>